|
Market Cap (16-May) $246,695,168 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (5-May) 39,772 (0.02%) (495th) |
|
52w High $2.09 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 3 March 2023, 15:30. The announcement is not marked as price sensitive, and is 2 page(s) in length and 206.9kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.000% short sold according to ASIC data. It was ranked the 629th most shorted stock on the ASX. It is now ranked as the 495th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Replacement Appendix 3Y - Damian Clarke Bruce | 3 March 2023, 15:30 |
| Appendix 3Y x 3 | 3 March 2023, 15:03 |
| Notification regarding unquoted securities - RAC | 3 March 2023, 14:39 |
| New Collaboration to Understand Zantrene Cardioprotection | 2 March 2023, 12:33 |
You must be logged in to post a reply.
Race Oncology 